kabutan

SEIKAGAKU CORPORATION(4548) Summary

4548
TSE Prime
SEIKAGAKU CORPORATION
702
JPY
-4
(-0.57%)
Apr 30, 9:34 am JST
4.38
USD
Apr 29, 8:34 pm EDT
Result
PTS
outside of trading hours
701.1
Apr 30, 9:27 am JST
Summary Chart Historical News Financial Result
PER
42.6
PBR
0.52
Yield
4.27%
Margin Trading Ratio
16.63
Stock Price
Apr 30, 2026
Opening Apr 30, 9:00 am
703 JPY 4.38 USD
Previous Close Apr 28
706 JPY 4.43 USD
High Apr 30, 9:01 am
705 JPY 4.40 USD
Low Apr 30, 9:13 am
700 JPY 4.37 USD
Volume
15,300
Trading Value
0.01B JPY 0.07M USD
VWAP
702.31 JPY 4.39 USD
Minimum Trading Value
70,200 JPY 438 USD
Market Cap
0.04T JPY 0.25B USD
Number of Trades
44
Liquidity & Number of Trades
As of Apr 30, 2026
Liquidity
Mid
1-Year Average
293
1-Year High Dec 2, 2025
1,012
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 98,100 552,000 5.63
Apr 17, 2026 95,200 478,000 5.02
Apr 10, 2026 82,800 481,000 5.81
Apr 3, 2026 89,400 412,100 4.61
Mar 27, 2026 100,200 440,200 4.39
Company Profile
SEIKAGAKU CORPORATION specializes in the development of products related to joint diseases. Its hyaluronic acid preparations are distributed through partnerships with Kaken Pharmaceutical and Santen Pharmaceutical.
Sector
Pharmaceuticals
SEIKAGAKU CORPORATION engages in the research, development, manufacturing, procurement, and sales of pharmaceuticals and LAL (Limulus Amebocyte Lysate) products, including endotoxin detection reagents. In its pharmaceutical business, the company focuses on joint function improving agents as its main product line, while also offering ophthalmic surgical aids and treatments for lumbar disc herniation. Additionally, the company manufactures pharmaceutical ingredients and provides contract manufacturing services for pharmaceuticals. In the LAL business, SEIKAGAKU CORPORATION offers endotoxin detection reagents and glucan measurement in vitro diagnostic products. The company has several subsidiaries both domestically and internationally, conducting pharmaceutical and medical device development in North America, as well as manufacturing and sales operations overseas.